Successful use of spesolimab in refractory pyoderma gangrenosum.

Authors

• Alexa Lum
• Suraj Patel, Corewell Health East Resident
• Joshua Aron, Corewell Health East Resident
• Francisca Kartono, Corewell Health East

Document Type

Article

Publication Date

2-17-2026

Publication Title

JAAD case reports

Volume

70

First Page

210

Last Page

212

Recommended Citation

Lum A, Patel S, Aron J, Kartono F. Successful use of spesolimab in refractory pyoderma gangrenosum. JAAD Case Rep. 2026 Feb 17;70:210-212. doi: 10.1016/j.jdcr.2026.02.026. PMID: 41859428

DOI

10.1016/j.jdcr.2026.02.026

ISSN

2352-5126

PubMed ID

41859428